Advertisement
Research Article| Volume 7, ISSUE 1, P57-74, January 1991

Thyrotoxicosis in the Critically Ill

  • Charles A. Reasner II
    Correspondence
    Address requests for reprints to: Charles A. Reasner, II, MD, Assistant Professor of Medicine, Division of Endocrinology and Metabolism, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284-7877
    Affiliations
    Assistant Professor of Medicine, Division of Endocrinology and Metabolism, University of Texas Health Science Center at San Antonio, San Antonio, Texas
    Search for articles by this author
  • William L. Isley
    Affiliations
    Associate Professor of Medicine, and Chief, Section of Endocrinology and Metabolism, University of Missouri-Eansac City School cf Medicine, Kansas City, Missouri
    Search for articles by this author
DOI:https://doi.org/10.1016/S0749-0704(18)30323-3
Thyrotoxicosis in the Critically Ill
Previous ArticleMyxedema Coma
Next ArticleHypoglycemia
      This paper is only available as a PDF. To read, Please Download here.
      The most common reason for failure to successfully treat the seriously ill thyrotoxic patient is failure to recognize the patient’s primary condition as a thyroid disorder. Congestive heart failure, tachyarrhythmias, neurologic deterioration, or unexplained weight loss commonly lead the physician to embark on a diagnostic workup of a presumed nonthyroidal disease. Timely treatment aimed at the cause and effects of thyrotoxicosis is essential to ameliorate the deleterious effects of thyroid hormone excess in the seriously ill patient.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Anaissie E.
        • Tohmé J.F.
        Reserpine in propranolol-resistant thyroid storm.
        Arch Intern Med. 1985; 145: 2248
        • Andersson R.G.G.
        • Nilsson O.R.
        • Kuo J.F.
        β-Adrenoceptor-adenosine 3’,5’-monophosphate system in human leukocytes before and after treatment For hyperthyroidism.
        J Clin Endocrinol Metab. 1983; 56: 42
        • Arteaga E.
        • Lopez J.M.
        • Rodriguez J.A.
        • et al.
        Effect of the combination of dexamethasone and sodium ipodate on serum thyroid hormones in Graves’s disease.
        Clin Endocrinol. 1983; 19: 619
        • Ashkar F.S.
        • Katims R.B.
        • Smoak III, W.M.
        • et al.
        Thyroid storm treatment with blood exchange and plasmapheresis.
        JAMA. 1970; 214: 1275
        • Bar-Sela S.
        • Ehrenfeld M.
        • Eliakim M.
        Arterial embolism in thyrotoxicosis with atrial fibrillation.
        Arch Intern Med. 1981; 141: 1191
        • Bartle W.R.
        • Walker S.E.
        • Silverberg D.H.
        Rectal absorption of propylthiouracil.
        Int J Clin Pharm. 1988; 26: 285
        • Bauman J.H.
        • Teichman S.
        • Wible D.A.
        Increased theophylline clearance in a patient with hyperthyroidism.
        Ann Allergy. 1984; 52: 94
        • Becker D.V.
        Choice of therapy for Graves’ hyperthyroidism.
        N Engl J Med. 1984; 311: 464
        • Bilezikian J.P.
        • Loeb J.N.
        The influence of hyperthyroidism and hypothyroidism on α and β-adrenergic receptor systems and adrenergic responsiveness.
        Endocrinol Rev. 1983; 4: 378
        • Bitton R.N.
        • Wexler C.
        Free triiodothyronine toxicosis: A distinct entity.
        Am J Med. 1990; 88: 531
        • Boehm T.M.
        • Burman K.D.
        • Barnes S.
        • et al.
        Lithium and iodine combination therapy.
        Acta Endocrinol. 1980; 94: 174
        • Borowski G.D.
        • Garofano C.D.
        • Rose L.I.
        • et al.
        Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function.
        Am J Med. 1985; 78: 443
        • Braithwaite S.S.
        • Brooks M.H.
        • Collins S.
        • et al.
        Plasmapheresis: An adjunct to medical management of severe hyperthyroidism.
        J Clin Apheresis. 1986; 3: 119
        • Brooks M.H.
        • Waldstein S.S.
        Free thyroxine concentrations in thyroid storm.
        Ann Intern Med. 1980; 93: 694
        • Burrow G.N.
        The management of thyrotoxicosis in pregnancy.
        N Engl J Med. 1983; 313: 562
        • Caplan R.H.
        • Pagliara A.S.
        • Wickus G.
        Thyroxine toxicosis.
        JAMA. 1980; 244: 1934
        • Cavalieri R.R.
        Quantitative in vivo tests.
        in: Ingbar S.H. Braverman L.E. The Thyroid. ed 5. JB Lippincott, St Louis1986: 445
        • Chang D.C.S.
        • Wheeler M.H.
        • Woodcock J.P.
        • et al.
        The effect of preoperative Lugol’s iodine on thyroid blood flow in patients with Graves’ hyperthyroidism.
        Surgery. 1987; 102: 1055
        • Cooper D.S.
        Propylthiouracil levels in hyperthyroid patients unresponsive to large doses.
        Ann Intern Med. 1985; 102: 328
        • Cooper D.S.
        • Steigerwalt S.
        • Migdal S.
        Pharmacology of propylthiouracil in thyrotoxicosis and chronic renal failure.
        Arch Intern Med. 1987; 147: 785
        • Cooper D.S.
        Which antithyroid drug?.
        Am J Med. 1986; 80: 1165
        • Cooper D.S.
        • Ridgway E.C.
        Clinical management of patients with hyperthyroidism.
        Med Clin North Am. 1985; 69: 953
        • Crile G.
        The treatment of hyperthyroidism.
        World J Surg. 1978; 2: 279
        • Croxson M.S.
        • Hall T.D.
        • Nicoloff J.T.
        Combination drug therapy for treatment of hyperthyroid Graves’ disease.
        J Clin Endocrinol Metab. 1977; 45: 623
        • Croxson M.S.
        • Ibbertson H.K.
        Serum digoxin in patients with thyroid disease.
        Br Med J. 1975; 3: 566
        • Dahlstrom C.G.
        • Ladefoged S.D.
        Verapamil in atrial fibrillation in hyperthyroidism.
        Br Med J. 1987; 294: 1384
        • Davis L.E.
        • Lucas M.J.
        • Hankins G.D.
        • et al.
        Thyrotoxicosis complicating pregnancy.
        Am J Obstet Gynecol. 1989; 160: 63
        • Davis P.J.
        • Davis F.B.
        Hyperthyroidism in patients over the age of 60 years.
        Medicine. 1974; 53: 161
        • Dillon P.T.
        • Babe J.
        • Meloni C.R.
        • et al.
        Reserpine in thyrotoxic crisis.
        N Engl J Med. 1970; 283: 1021
        • Dodd M.J.
        • Blake D.R.
        A case of apathetic thyrotoxicosis simulating malignant disease.
        Postgrad Med J. 1980; 56: 359
        • Dunn J.T.
        Choice of therapy in young adults with hyperthyroidism of Graves’ disease.
        Ann Intern Med. 1984; 100: 891
        • Engler D.
        • Donaldson E.B.
        • Stockigt J.R.
        • et al.
        Hyperthyroidism without triiodothyronine excess: An effect of severe nonthyroidal illness.
        J Clin Endocrinol Metab. 1978; 46: 77
        • Erriksson M.A.
        • Rubenfeld S.
        • Garber A.J.
        • et al.
        Propranolol does not prevent thyroid storm.
        N Engl J Med. 1977; 296: 263
        • Feek C.M.
        • Sawers J.SA.
        • Irvine W.J.
        • et al.
        Combination of potassium iodide and propranolol in preparation of patients with Graves’ disease for thyroid surgery.
        N Engl J Med. 1980; 302: 883
        • Feely J.
        • Stevenson I.H.
        • Crooks J.
        Altered plasma protein binding of drugs in thyroid disease.
        Clin Pharmacol. 1981; 6: 298
        • Feely J.
        • Stevenson I.H.
        • Crooks J.
        Increased clearance of propranolol in thyrotoxicosis.
        Ann Intern Med. 1981; 94: 472
        • Feely J.
        • Peden N.
        Use of β-adrenoceptor blocking drugs in hyperthyroidism.
        Drugs. 1984; 27: 425
        • Forfar J.C.
        • Muir A.L.
        • Sawers S.A.
        • et al.
        Abnormal left ventricular function in hyperthyroidism.
        N Engl J Med. 1982; 307: 1165
        • Forfar J.C.
        • Caldwell G.C.
        Hyperthyroid heart disease.
        Clin Encocrinol Metab. 1985; 14: 491
        • Forfar J.C.
        • Miller H.C.
        • Toft A.D.
        Occult thyrotoxicosis: A correctable cause of "idiopathic" atrial fibrillation.
        Am J Cardiol. 1979; 44: 9
        • Fradkin J.E.
        • Wolff J.
        Iodide-induced thyrotoxicosis.
        Medicine. 1983; 62: 1
        • Freeman M.
        • Giuliani M.
        • Schwartz E.
        • et al.
        Acute thyroiditis, thyroid crisis, and hypocalcemia following radioactive iodine therapy.
        NY State Med J. 1969; 69: 2036
        • Frishman W.H.
        β-Adrenergic blockers.
        Med Clin North Am. 1988; 72: 37
        • Gamstedt A.
        • Kagedal B.
        • Tegler L.
        Serum free thyroid hormones are decreased by betamethasone treatment in Graves’ disease.
        Horm Metab Res. 1988; 20: 54
        • Gerst P.H.
        • Fildes J.
        • Baylor P.
        • et al.
        Long-acting ^-adrenergic antagonists as preparation for surgery in thyrotoxicosis.
        Arch Surg. 1986; 121: 838
        • Gossage A.AR.
        • Munro D.S.
        The pathogenesis of Graves’ disease.
        Clin Endocrinol Metab. 1985; 14: 299
        • Graham G.D.
        • Burman K.D.
        Radioiodine treatment of Graves’s disease.
        Ann Intern Med. 1986; 105: 900
        • Greenberger N.J.
        • Milligan F.D.
        • DeGroot L.J.
        • et al.
        Jaundice and thyrotoxicosis in the absence of congestive heart failure.
        Am J Med. 1964; 36: 840
        • Greer M.A.
        Thyrotoxicosis of extrathyroid origin.
        in: Ingbar S.H. Braverman L.E. The Thyroid. ed 5. JB Lippincott, Philadelphia1986: 1120
        • Greenspan A.M.
        • Horowitz L.N.
        Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function.
        Am J Med. 1985; 78: 443
        • Hamblin P.S.
        • Mohr V.S.
        • Stockigt J.R.
        • et al.
        lopanoic acid is of minimal benefit in the treatment of severe hyperthyroidism: Conclusions from a case study.
        Clin Endocrinol. 1985; 22: 503
        • Hamilton C.R.
        • Maloof F.
        Unusual types of hyperthyroidism.
        Medicine. 1973; 52: 195
        • Hedberg C.W.
        • Fishbein D.B.
        • Janssen R.S.
        • et al.
        An outbreak of thyrotoxicosis caused by consumption of bovine thyroid gland in ground beef.
        N Engl J Med. 1987; 316: 993
        • Herman V.S.
        • Joffe B.I.
        • Kalk W.J.
        • et al.
        Clinical and biochemical responses to nadolol and clonidine in hyperthyroidism.
        J Clin Pharmacol. 1989; 29: 1117
        • Hershman J.M.
        Hyperthyroidism caused by trophoblastic tumors.
        in: Ingbar S.H. Braverman L.E. The Thyroid. ed 5. JB Lippincott, Philadelphia1986: 1085
        • Hollingsworth D.R.
        Hyperthyroidism in pregnancy.
        in: Ingbar S.H. Braverman L.E. The Thyroid. ed 5. JB Lippincott, Philadelphia1986: 1043
        • Ingbar S.H.
        Classification of the causes of thyrotoxicosis.
        in: Ingbar S.H. Braverman L.E. The Thyroid. ed 5. JB Lippincott, Philadelphia1986: 809
        • Isley W.L.
        Thyroid disease.
        in: Civetta J.M. Taylor R.W. Kirby R.R. Critical Care. JB Lippincott, Philadelphia1988: 1415
        • Isley W.L.
        Effect of rifampin therapy on thyroid function tests in a hypothyroid patient on replacement L-thyroxine.
        Ann Intern Med. 1987; 107: 517

      60. Isley WL, Dahl S, Gibbs H: Use of esmolol in managing a thyrotoxic patient needing emergency surgery. Am J Med, in press

        • Jabbari B.
        • Kuott A.D.
        Seizures in thyrotoxicosis.
        Epilepsia. 1980; 21: 91
        • Jones M.K.
        • Solomon S.
        Thyrotoxic crisis masked by treatment with β-blockers.
        Br Med J. 1981; 283: 659
        • Klein I.
        • Levey G.S.
        New perspectives on thyroid hormone, catecholamines, and the heart.
        Am J Med. 1984; 76: 167
        • Kourides I.A.
        TSH-induced hyperthyroidism.
        in: Ingbar S.H. Braverman L.E. The Thyroid. ed 5. JB Lippincott, Philadelphia1986: 1064
        • Larsen P.R.
        Thyroid hormone concentrations.
        in: Ingbar S.H. Braverman L.E. The Thyroid. ed 5. JB Lippincott, Philadelphia1986: 479
        • Lum S.MC.
        • Kaptein E.M.
        • Nicoloff J.T.
        Influence of nonthyroidal illnesses on serum thyroid hormone indices in hyperthyroidism.
        West J Med. 1983; 138: 670
        • Mackin J.F.
        • Canary J.J.
        • Pittman C.S.
        Thyroid storm and its management.
        N Engl J Med. 1974; 291: 1396
        • Mariotti S.
        • Martino E.
        • Cupini C.
        • et al.
        Low serum thyroglobulin as a clue to the diagnosis of thyrotoxicosis factitia.
        N Engl J Med. 1982; 307: 410
        • Marsden P.
        • Facer P.
        • Acosta M.
        • et al.
        Serum triiodothyronine in solitary autonomous nodules of the thyroid.
        Clin Endocrinol. 1975; 4: 327
        • Martino E.
        • Aghini-Lombardi A.
        • Lippi F.
        • et al.
        Twenty-four-hour radioactive iodine uptake in 35 patients with amiodarone-associated thyrotoxicosis.
        J Nucl Med. 1985; 26: 1402
        • Mazzaferri E.L.
        • Skillman T.G.
        Thyroid storm.
        Arch Intern Med. 1969; 124: 684
        • Medeiros-Neto G.A.
        Triiodothyronine thyrotoxicosis.
        in: Ingbar S.H. Braverman L.E. The Thyroid. ed 5. JB Lippincott, Philadelphia1986: 1429
        • Milner M.R.
        • Gelman K.M.
        • Phillips R.A.
        • et al.
        Double-blind crossover trial of diltiazem versus propranolol in the management of thyrotoxic symptoms.
        Pharmacotherapy. 1990; 10: 100
        • Momotani N.
        • Noh J.
        • Oyanagi H.
        • et al.
        Antithyroid drug therapy for Graves’ disease during pregnancy.
        N Engl J Med. 1986; 315: 24
        • Nakazawa H.K.
        • Sakurai K.
        • Hamada N.
        • et al.
        Management of atrial fibrillation in the post-thyrotoxic state.
        Am J Med. 1982; 72: 903
        • Newcomer J.
        • Haire W.
        • Hartman C.
        Coma and thyrotoxicosis.
        Ann Neurol. 1983; 14: 689
        • Nicoloff J.T.
        Thyroid storm and myxedema coma.
        Med Clin North Am. 1985; 69: 1005
        • Nikolai T.F.
        Silent thyroiditis.
        in: Ingbar S.H. Braverman L.E. The Thyroid. ed 5. JP Lippincott, Philadelphia1986: 1098
        • Noguchi K.
        • Suzuki H.
        • Nakahata M.
        • et al.
        Prolonged treatment of hyperthyroidism with sodium tyropanoate, an oral cholecystographic agent: A re-evaluation of its clinical utility.
        Clin Endocrinol. 1986; 25: 293
        • Orgiazzi J.
        Management of Graves’ hyperthyroidism.
        Endocrinol Metab Clin North Am. 1987; 16: 365
        • Ozawa Y.
        • Dai d.a H.
        • Shimizu T.
        • et al.
        Rapid improvement of thyroid function by using glucocorticoid indicated for the preoperative preparation of subtotal thyroidectomy on Graves’s disease.
        Endocrinol Jpn. 1983; 30: 93
        • Peden N.R.
        • Gunn A.
        • Browning M.CK.
        • et al.
        Nadolol and potassium iodide in combination in the surgical treatment of thyrotoxicosis.
        Br J Surg. 1982; 69: 638
        • Perrild H.
        • Hansen J.M.
        • Skovsted L.
        • et al.
        Different effects of propranolol, alpresnolol, sotalol, atenolol, metoprolol on serum T3 and serum rT3 in hyperthyroidism.
        Clin Endocrinol. 1983; 18: 139
        • Reasner II, C.A.
        • Isley W.L.
        Thyroid scanning in patients with suspected thyroid disease.
        Ann Intern Med. 1985; 102: 209
        • Roti E.
        • Robuschi G.
        • Gardini E.
        • et al.
        Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves’ disease.
        Clin Endocrinol. 1988; 28: 305
        • Roti E.
        • Montermini M.
        • Roti S.
        • et al.
        The effect of diltiazem, a calcium channel blocking drug, on cardiac rate and rhythm in hyperthyroid patients.
        Arch Intern Med. 1988; 148: 1919
        • Rubenfeld S.
        • Silverman V.E.
        • Welch K.MA.
        • et al.
        Variable plasma propranolol levels in thyrotoxicosis.
        N Engl J Med. 1979; 300: 353
        • Schwartz M.
        • Michelson E.L.
        • Sawin H.S.
        • et al.
        Esmolol: Safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias.
        Chest. 1988; 93: 705
        • Seth J.
        • Beckett G.
        Diagnosis of hyperthyroidism: The newer biochemical tests.
        Clin Endocrinol Metab. 1985; 14: 378
        • Shenfield G.M.
        Influence of thyroid dysfunction on drug pharmacokinetics.
        Clin Pharm. 1981; 6: 275
        • Silverstein E.
        • Schussler G.C.
        • Friedland J.
        Elevated serum angiotensin converting enzyme in hyperthyroidism.
        Am J Med. 1983; 75: 233
        • Solomon B.
        • Wartofsky L.
        • Burman K.D.
        Cholestyramine treatment of thyrotoxicosis (abstract #329).
        Program of The Endocrine Society, 72nd Annual Meeting. 1990
        • Solomon D.H.
        Treatment of Graves’ hyperthyroidism.
        in: Ingbar S.H. Braverman L.E. The Thyroid. ed 5. JB Lippincott, Philadelphia1986: 987
        • Spencer C.A.
        Clinical utility and cost effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients.
        Mayo Clin Proc. 1988; 63: 1214
        • Staffurth J.S.
        • Gibberd M.C.
        • Fui S.NT.
        Arterial embolism in thyrotoxicosis with atrial fibrillation.
        Br Med J. 1977; 2: 688
        • Studer H.
        • Peter H.J.
        • Gerber H.
        Toxic nodular goitre.
        Clin Endocrinol Metab. 1985; 14: 351
        • Tajiri J.
        • Noguchi S.
        • Murakami T.
        • et al.
        Antithyroid drug-induced agranulocytosis.
        Arch Intern Med. 1990; 150: 621
        • Thomas F.B.
        • Mazzaferri E.L.
        • Skillman T.G.
        Apathetic thyrotoxicosis: A distinctive clinical and laboratory entity.
        Ann Intern Med. 1970; 72: 679
        • Thorne A.C.
        • Bedford R.F.
        Esmolol for perioperative management of thyrotoxic goiter.
        Anesthesiology. 1989; 71: 291-295
        • Tibaldi J.M.
        • Barzel U.S.
        • Albin J.
        • et al.
        Thyrotoxicosis in the very old.
        Am J Med. 1986; 81: 619
        • Totterman T.H.
        • Karlsson F.A.
        • Bengtsson M.
        Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves’ disease.
        N Engl J Med. 1987; 316: 15
        • Turlapaty P.
        • Laddu A.
        • Shrinivas V.
        • et al.
        Esmolol: A titratable short-acting intravenous /5-blocker for acute critical care settings.
        Clin Pharm. 1987; 114: 866
        • Urbanic R.C.
        • Mazzaferri E.L.
        Thyrotoxic crisis and myxedema coma.
        Heart Lung. 1978; 7: 435
        • Utiger R.D.
        The thyroid: Hyperthyroidism, hypothyroidism, and the painful thyroid.
        in: Felig P. Baxter J.D. Broadus A.E. et a.l. Endocrinology and Metabolism. ed 2. McGraw Hill, New York1987: 389
        • Volpe R.
        Subacute thyroiditis.
        in: Ingbar S.H. Braverman L.E. The Thyroid. JP Lippincott, Philadelphia1986: 1106
        • Volpe R.
        • Karlsson A.
        • Jansson R.
        • et al.
        Thyrostatic drugs act through modulation of thyroid cell activity to induce remissions in Graves’ disease.
        Acta Endocrinol. 1987; 281: 305
        • Waldstein S.S.
        • West Jr., G.H.
        • Lee W.Y.
        • et al.
        Guanethidine in hyperthyroidism.
        JAMA. 1964; 189: 609
        • Walfish P.G.
        • Chan J.Y.C.
        Postpartum hyperthyroidism.
        Clin Endocrinol Metab. 1985; 14: 417
        • Wartofsky L.
        Thyrotoxic storm.
        in: Ingbar S.H. Braverman L.E. The Thyroid. ed 5. JB Lippincott, Philadelphia1986: 974
        • Wartofsky L.
        • Ransil B.J.
        • Ingbar S.H.
        Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis.
        J Clin Invest. 1970; 49: 78
        • Werner M.C.
        • Romaldini J.H.
        • Brombert N.
        • et al.
        Adverse effects related to thionamide drugs and their dose regimen.
        Am J Med Sci. 1989; 297: 216
        • Wilkinson R.
        • Burr W.A.
        A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis.
        Am Heart J. 1984; 108: 1160
        • Williams D.E.
        • Chopra I.J.
        • Orgiazzi J.
        • et al.
        Acute effects of corticosteroids on thyroid activity in Graves’ disease.
        J Clin Endocrinol Metab. 1975; 41: 354
        • Wing S.S.
        • Fantus G.
        Adverse immunologic effects of antithyroid drugs.
        Can Med Assoc J. 1987; 136: 121
        • Wu S.Y.
        • Shyh T.P.
        • Chopra I.J.
        • et al.
        Comparison of sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism.
        J Clin Endcciniol Metab. 1982; 54: 630
        • Zakarija M.
        • McKenzie J.M.
        The spectrum and significance of autoantibodies reacting with the thyrotropin receptor.
        Endocrinol Metab Clin North Am. 1987; 16: 343
        • Zonszein J.
        • Santangelo R.P.
        • Mackin J.F.
        • et al.
        Propranolol therapy in thyrotoxicosis.
        Am J Med. 1979; 66: 411

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0749-0704(18)30323-3

      Copyright

      © 1991 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX